used the differential expression of KDR in vascular endothelial cells between tumor tissues and normal tissues, and designed a KDR promoter-based HSV-TK expression adenovirus-mediated transfer system (AdKDR-tk), which only targeted expression of HSV-TK in tumor vascular endothelial cells. This evidence concerns the gene KDR and neoplasm.